Eli Lilly and Statistics
Share Statistics
Eli Lilly and has 947.74M
shares outstanding. The number of shares has increased by -0.25%
in one year.
| Shares Outstanding | 947.74M |
| Shares Change (YoY) | -0.25% |
| Shares Change (QoQ) | -0.14% |
| Owned by Institutions (%) | 86.18% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 1 |
| FTD / Avg. Volume | n/a |
Short Selling Information
The latest short interest is 6.43M, so 0.72% of the outstanding
shares have been sold short.
| Short Interest | 6.43M |
| Short % of Shares Out | 0.72% |
| Short % of Float | 0.81% |
| Short Ratio (days to cover) | 1.59 |
Valuation Ratios
The PE ratio is 65.65 and the forward
PE ratio is 26.28.
Eli Lilly and's PEG ratio is
0.65.
| PE Ratio | 65.65 |
| Forward PE | 26.28 |
| PS Ratio | 15.44 |
| Forward PS | 7.1 |
| PB Ratio | 48.99 |
| P/FCF Ratio | 1678.17 |
| PEG Ratio | 0.65 |
Financial Ratio HistoryEnterprise Valuation
Eli Lilly and has an Enterprise Value (EV) of 725.64B.
| EV / Sales | 16.11 |
| EV / EBITDA | 47.65 |
| EV / EBIT | 82.29 |
| EV / FCF | 1751.49 |
Financial Position
The company has a current ratio of 1.15,
with a Debt / Equity ratio of 2.37.
| Current Ratio | 1.15 |
| Quick Ratio | 1.15 |
| Debt / Equity | 2.37 |
| Debt / EBITDA | 2.21 |
| Debt / FCF | 81.21 |
| Interest Coverage | 22.42 |
Financial Efficiency
Return on Equity is 74.62% and Return on Invested Capital is 29.04%.
| Return on Equity | 74.62% |
| Return on Assets | 13.45% |
| Return on Invested Capital | 29.04% |
| Revenue Per Employee | $958,355.32 |
| Profits Per Employee | $225,319.15 |
| Employee Count | 47,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 2.09B |
| Effective Tax Rate | 16.49% |
Stock Price Statistics
The stock price has increased by -2.54% in the
last 52 weeks. The beta is 0.47, so Eli Lilly and's
price volatility has been higher than the market average.
| Beta | 0.47 |
| 52-Week Price Change | -2.54% |
| 50-Day Moving Average | 823.3 |
| 200-Day Moving Average | 841.49 |
| Relative Strength Index (RSI) | 40.37 |
| Average Volume (20 Days) | 3,851,362 |
Income Statement
In the last 12 months, Eli Lilly and had revenue of 45.04B
and earned 10.59B
in profits. Earnings per share was 11.76.
| Revenue | 45.04B |
| Gross Profit | 36.62B |
| Operating Income | 17.5B |
| Net Income | 10.59B |
| EBITDA | 15.23B |
| EBIT | 13.46B |
| Earnings Per Share (EPS) | 11.76 |
Full Income StatementBalance Sheet
The company has 3.27B in cash and 33.64B in
debt, giving a net cash position of -30.38B.
| Cash & Cash Equivalents | 3.27B |
| Total Debt | 33.64B |
| Net Cash | -30.38B |
| Retained Earnings | n/a |
| Total Assets | 89.39B |
| Working Capital | 11.19B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 8.82B
and capital expenditures -8.4B, giving a free cash flow of 414.3M.
| Operating Cash Flow | 8.82B |
| Capital Expenditures | -8.4B |
| Free Cash Flow | 414.3M |
| FCF Per Share | 0.46 |
Full Cash Flow StatementMargins
Gross margin is 81.31%, with operating and profit margins of 38.86% and 23.51%.
| Gross Margin | 81.31% |
| Operating Margin | 38.86% |
| Pretax Margin | 28.15% |
| Profit Margin | 23.51% |
| EBITDA Margin | 33.81% |
| EBIT Margin | 38.86% |
| FCF Margin | 0.92% |
Dividends & Yields
LLY pays an annual dividend of $6.7,
which amounts to a dividend yield of 0.64%.
| Dividend Per Share | $6.70 |
| Dividend Yield | 0.64% |
| Dividend Growth (YoY) | 15.38% |
| Payout Ratio | 54.6% |
| Earnings Yield | 1.52% |
| FCF Yield | 0.06% |
Dividend DetailsAnalyst Forecast
The average price target for LLY is $1001,
which is 33.1% higher than the current price. The consensus rating is "Buy".
| Price Target | $1001 |
| Price Target Difference | 33.1% |
| Analyst Consensus | Buy |
| Analyst Count | 26 |
Stock ForecastsStock Splits
The last stock split was on Oct 16, 1997. It was a
forward
split with a ratio of 2:1.
| Last Split Date | Oct 16, 1997 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 7.87 |
| Piotroski F-Score | 7 |
